My Quote Request
6505000033026
20 Products
GOLDLINE
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
GOLDLINE
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
GOLDLINE
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00469-2067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017673
NSN
6505-00-001-7673
NDC00469-2067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017673
NSN
6505-00-001-7673
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENT 3 GM POTASSIUM CHLORIDE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
NDC00469-2067-15
POTASSIUM CHLORIDE INJECTION,USP
NSN
6505-00-001-7673
MFG
LYPHOMED INC DIV OF FUJISAWA USA INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENT 3 GM POTASSIUM CHLORIDE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
NDC00517-2120-01
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017673
NSN
6505-00-001-7673
NDC00517-2120-01
POTASSIUM CHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017673
NSN
6505-00-001-7673
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENT 3 GM POTASSIUM CHLORIDE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
NDC00517-2120-01
POTASSIUM CHLORIDE INJECTION,USP
NSN
6505-00-001-7673
MFG
LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: ACTIVE INGREDIENT 3 GM POTASSIUM CHLORIDE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 20.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 1
NDC00641-1496-35
PROMETHAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017674
NSN
6505-00-001-7674
NDC00641-1496-35
PROMETHAZINE HYDROCHLORIDE INJECTION,USP
NSN, MFG P/N
6505000017674
NSN
6505-00-001-7674
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROMETHAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROMETHAZINE HYDROCHLORIDE INJECTION USP 1 ML AMPUL 25 PACKAGE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
NDC00641-1496-35
PROMETHAZINE HYDROCHLORIDE INJECTION,USP
NSN
6505-00-001-7674
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS PROMETHAZINE HYDROCHLORIDE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PROMETHAZINE HYDROCHLORIDE INJECTION USP 1 ML AMPUL 25 PACKAGE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 25
2F7184
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
NDC00074-6143-09
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
NDC00074-6143-09
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
NDC00074-6143-09
ACETIC ACID IRRIGATION,USP
NSN
6505-00-001-7676
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
NDC00264-2304-00
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
NDC00264-2304-00
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
NDC00338-0656-04
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
NDC00338-0656-04
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
NDC00338-0656-04
ACETIC ACID IRRIGATION,USP
NSN
6505-00-001-7676
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
R6600
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
R6600-01
ACETIC ACID IRRIGATION,USP
NSN, MFG P/N
6505000017676
NSN
6505-00-001-7676
MFG
B BRAUN MEDICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 PERCENTAGE, W/V ACETIC ACID ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, PLASTIC
54670
RIFAMPIN CAPSULES,USP
NSN, MFG P/N
6505000033022
NSN
6505-00-003-3022
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS RIFAMPIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
54670
RIFAMPIN CAPSULES,USP
NSN
6505-00-003-3022
MFG
MERRELL DOW PHARMECEUTICALS INC BIDS AND CONTRACTS DEPT
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS RIFAMPIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 60.000
CAPSULE TYPE: HARD
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:NONENTERIC FILM
LEVOTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
LEVOTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
LEVOTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
LEVOTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
LEVOTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
LEVOTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00048-1140-05
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
NDC00048-1140-05
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00048-1140-05
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00053-2545-04
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
NDC00053-2545-04
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00053-2545-04
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
ARMOUR PHARMACEUTICAL CO DIV OF RORER-POULEC RORER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00182-0639-10
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
NDC00182-0639-10
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00182-0639-10
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505000033026
NSN
6505-00-003-3026
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN
6505-00-003-3026
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.200 MILLIGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
NDC00046-0868-91
ESTROGENS,CONJUGATED,TABLETS,USP
NSN, MFG P/N
6505000035111
NSN
6505-00-003-5111
NDC00046-0868-91
ESTROGENS,CONJUGATED,TABLETS,USP
NSN, MFG P/N
6505000035111
NSN
6505-00-003-5111
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS ESTROGENIC SUBSTANCES, CONJUGATED ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROGENS CONJUGATE TABLETS USP 0.3 MG 1000 TABLETS PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PREMARIN BY AYERST LABORATORIES
NDC00046-0868-91
ESTROGENS,CONJUGATED,TABLETS,USP
NSN
6505-00-003-5111
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS ESTROGENIC SUBSTANCES, CONJUGATED ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROGENS CONJUGATE TABLETS USP 0.3 MG 1000 TABLETS PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PREMARIN BY AYERST LABORATORIES
PREMARIN
ESTROGENS,CONJUGATED,TABLETS,USP
NSN, MFG P/N
6505000035111
NSN
6505-00-003-5111
PREMARIN
ESTROGENS,CONJUGATED,TABLETS,USP
NSN, MFG P/N
6505000035111
NSN
6505-00-003-5111
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS ESTROGENIC SUBSTANCES, CONJUGATED ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROGENS CONJUGATE TABLETS USP 0.3 MG 1000 TABLETS PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PREMARIN BY AYERST LABORATORIES
PREMARIN
ESTROGENS,CONJUGATED,TABLETS,USP
NSN
6505-00-003-5111
MFG
WYETH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS ESTROGENIC SUBSTANCES, CONJUGATED ACTIVE INGREDIENT
COATING FEATURE: SUGAR
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ESTROGENS CONJUGATE TABLETS USP 0.3 MG 1000 TABLETS PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PREMARIN BY AYERST LABORATORIES
NDC00332-3167-07
MINOCYCLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505000035112
NSN
6505-00-003-5112
NDC00332-3167-07
MINOCYCLINE HYDROCHLORIDE CAPSULES,USP
NSN, MFG P/N
6505000035112
NSN
6505-00-003-5112
MFG
BIOCRAFT LABORATORIES INC CORPORATE HQ
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.080 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.006 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MINOCYCLINE HYDROCHLORIDE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINOCYCLINE HYDROCHLORIDE CAPSULES USP 100MG 50 CAPSULES BOTTLR
PRIMARY CONTAINER TYPE: BOTTLE
NDC00332-3167-07
MINOCYCLINE HYDROCHLORIDE CAPSULES,USP
NSN
6505-00-003-5112
MFG
BIOCRAFT LABORATORIES INC CORPORATE HQ
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 1.080 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 144
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 18.00 POUNDS
(NON-CORE DATA) INTERMEDIATE PACKAGE QUANTITY: 12
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.006 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.08 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS MINOCYCLINE HYDROCHLORIDE EQUIVALENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 50.000
CAPSULE TYPE: HARD
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MINOCYCLINE HYDROCHLORIDE CAPSULES USP 100MG 50 CAPSULES BOTTLR
PRIMARY CONTAINER TYPE: BOTTLE